Home › Funds › Siren, L.L.C. › BCAX

Siren, L.L.C. position in BCAX

Bicara Therapeutics Inc · Health Care

Siren, L.L.C. reported holding 5,502,970 shares of BCAX (Bicara Therapeutics Inc) in its Q3 2026 13F filing — a position valued at US$102.4M, representing 2.43% of its reported portfolio and ranking #11 among its reported holdings. Siren, L.L.C. has disclosed BCAX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)5.50M sh
Reported value held$102.41M
Portfolio Weight2.43%
First reportedQ3 2024
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s BCAX position evolved

Siren, L.L.C. first disclosed a stake in BCAX in Q3 2024 at 3,072,827 shares (US$78.3M). The position peaked in Q2 2026 at 5,602,970 shares, worth US$166.4M. Across 9 filings, Siren, L.L.C. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 5,502,970 shares valued at US$102.4M — a reduction of -100,000 shares quarter over quarter.. Notable position changes include a 60% increase in Q2 2025 (shares rose 70% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 3.07M $78.26M New
Q4 2024 3.27M $57.01M Add
Q1 2025 3.27M $42.57M Hold
Q2 2025 5.22M $48.47M Add
Q3 2025 5.22M $82.38M Hold
Q4 2025 5.22M $87.80M Hold
Q1 2026 5.80M $115.42M Add
Q2 2026 5.60M $166.35M Reduce
Q3 2026 5.50M $102.41M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BCAX and 13F data

BCAX (Bicara Therapeutics Inc) is a Health Care company. 54 other funds we track also report a position in BCAX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$215.4M), Vestal Point Capital, LP (US$155.9M), Deep Track Capital, LP (US$121.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BCAX

All BCAX fund holders →

FAQ

How long has Siren, L.L.C. held BCAX?

Siren, L.L.C. has disclosed BCAX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Siren, L.L.C.'s current position in BCAX?

As of Q3 2026, Siren, L.L.C. holds 5.50M shares of BCAX (Bicara Therapeutics Inc), valued at $102.41M, representing 2.43% of its reported portfolio and ranking #11.

Has Siren, L.L.C. been buying or selling BCAX?

In the latest 13F filing (Q3 2026), Siren, L.L.C. reduced its position in BCAX. The position peaked in Q2 2026 at 5.60M shares.

Which other funds hold BCAX?

Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Deep Track Capital, LP, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.